UGC Approved Journal no 63975(19)

ISSN: 2349-5162 | ESTD Year : 2014
Call for Paper
Volume 11 | Issue 4 | April 2024

JETIREXPLORE- Search Thousands of research papers



WhatsApp Contact
Click Here

Published in:

Volume 6 Issue 12
December-2019
eISSN: 2349-5162

UGC and ISSN approved 7.95 impact factor UGC Approved Journal no 63975

7.95 impact factor calculated by Google scholar

Unique Identifier

Published Paper ID:
JETIR1908114


Registration ID:
225295

Page Number

764-772

Share This Article


Jetir RMS

Title

A Review on Mushroom: A Cancer Antidote

Abstract

Cancer is the leading cause of death worldwide. The current anti-cancer drugs have numerous side effects. In a search for less toxic and effective treatment of cancer some prized mushrooms have been found to have validated anti-cancer properties. Numerous attempts have been made to assess their benefits for commercial purposes and cancer therapy. Certain bioactive molecules including polysaccharides, proteins, glycosides, alkaloids, volatile oils, tocopherols, phenolics, flavonoids, carotenoids, ascorbic acid enzymes, and organic acids which are also anti-tumour agents have been identified from various mushrooms. The anti-cancer potential of mushrooms lies in lentinan, krestin, hispolon, lectin, calcaelin, illudin S, psilocybin, Hericium polysaccharide A & B (HPA & HPB), ganoderic acid, schizophyllan, laccase, etc. Psilocybin mushrooms are used in folk medicine though it’s not considered edible. Over 50 mushroom species have been found to yield immunoceuticals with anti-cancer properties for animals including six for human cancers. PSP (Polysaccharide-peptide) over the last 5 year tests have significantly improved quality of life with substantial pain relief besides enhancing immune status in most patients with cancers of stomach, oesophagus, lung, ovary, and cervix. PSK (Polysaccharid-K) and PSP boosted immune cell production, ameliorated chemotherapy symptoms, and enhanced tumours infiltration by dendritic and cytotoxic T-cells. These chemicals have extremely low side-effects, improve the quality of life, and highly compatible with chemo therapy and hence, well suited for cancer management regimens. So here in this review paper, anti-cancer drugs produced by edible & wild both mushrooms & their activity to prevent & cure cancer has been discussed briefly.

Key Words

Keywords: Anti-cancer Drugs, Folk medicine, Immunoceuticals, cytotoxic T-cells, bioactive molecules.

Cite This Article

"A Review on Mushroom: A Cancer Antidote", International Journal of Emerging Technologies and Innovative Research (www.jetir.org), ISSN:2349-5162, Vol.6, Issue 12, page no.764-772, December 2019, Available :http://www.jetir.org/papers/JETIR1908114.pdf

ISSN


2349-5162 | Impact Factor 7.95 Calculate by Google Scholar

An International Scholarly Open Access Journal, Peer-Reviewed, Refereed Journal Impact Factor 7.95 Calculate by Google Scholar and Semantic Scholar | AI-Powered Research Tool, Multidisciplinary, Monthly, Multilanguage Journal Indexing in All Major Database & Metadata, Citation Generator

Cite This Article

"A Review on Mushroom: A Cancer Antidote", International Journal of Emerging Technologies and Innovative Research (www.jetir.org | UGC and issn Approved), ISSN:2349-5162, Vol.6, Issue 12, page no. pp764-772, December 2019, Available at : http://www.jetir.org/papers/JETIR1908114.pdf

Publication Details

Published Paper ID: JETIR1908114
Registration ID: 225295
Published In: Volume 6 | Issue 12 | Year December-2019
DOI (Digital Object Identifier):
Page No: 764-772
Country: Kolkata, West Bengal, India .
Area: Engineering
ISSN Number: 2349-5162
Publisher: IJ Publication


Preview This Article


Downlaod

Click here for Article Preview

Download PDF

Downloads

0003204

Print This Page

Current Call For Paper

Jetir RMS